Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: A prospective cohort study

Journal of Hypertension

Volumn 34, Issue 12, 2016, Pages 2449-2457

  Alexandre, Joachim ^a   Saloux, Eric ^a   Chequel, Mathieu ^a   Allouche, Stéphane ^a,b   Ollitrault, Pierre ^a   Plane, Anne Flore ^a   Legallois, Damien ^a,b   Fischer, Marc Olivier ^a,c   Saplacan, Vladimir ^a   Buklas, Dimitrios ^a   Labombarda, Fabien ^a   Blanchart, Katrien ^a   Salem, Joe Elie ^d   Nowoczyn, Marie ^a,b   Puddu, Paolo Emilio ^a,e   Manrique, Alain ^a,b   Parienti, Jean Jacques ^a   Milliez, Paul ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b électrophysiologie et imagerie des lésions d'ischémie reperfusion myocardique ^*  (Italy)

^c Pôle Réanimations Anesthésie SAMU SMUR   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aldosterone; Cardiac surgery; Galectin 3; Postoperative atrial fibrillation

Indexed keywords

ALDOSTERONE; BIOLOGICAL MARKER; GALECTIN 3;

AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; ADVERSE EFFECTS; BLOOD; CORONARY ARTERY BYPASS GRAFT; HEART ATRIUM; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALDOSTERONE; ATRIAL FIBRILLATION; BIOMARKERS; CORONARY ARTERY BYPASS; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84984674334     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001105     Document Type: Article

References (34)

1. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061-1073.
2. Simopoulos V, Tagarakis G, Hatziefthimiou A, Skoularigis I, Triposkiadis F, Trantou V, et al. Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: A retrospective study. Clin Res Cardiol 2015; 104: 31-37.
3. Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, et al. Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 1996; 276: 300-306.
4. Gialdini G, Nearing K, Bhave PD, Bonuccelli U, Iadecola C, Healey JS, et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 2014; 312: 616-622.
5. Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg 2014; 148: E153-e193.
6. Fellahi JL, Fornier W, Fischer MO, Bohadana D, Gerard JL, Hanouz JL. The impact of an algorithm on the optimization of beta-blockers after cardiac surgery. J Cardiothorac Vasc Anesth 2015; 29: 32-37.
7. Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, Mourad J-J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-1248.
8. Mayyas F, Alzoubi KH, Van Wagoner DR. Impact of aldosterone antagonists on the substrate for atrial fibrillation: Aldosterone promotes oxidative stress and atrial structural/electrical remodeling. Int J Cardiol 2013; 168: 5135-5142.
9. Alexandre J, Puddu P-E, Simard C, Hof T, Sallé L, Guinamard R, et al. Proarrhythmic effects of aldosterone during myocardial ischemiareperfusion: Implication of the sarcolemmal-KATP channels. J Cardiovasc Pharmacol 2014; 64: 134-141.
10. Alexandre J, Hof T, Puddu PE, Rouet R, Guinamard R, Manrique A, et al. Rapid and MR-independent IK1 activation by Aldosterone during ischemia-reperfusion. PLoS One 2015; 10: E0132592.
11. Petramala L, Pignatelli P, Carnevale R, Zinnamosca L, Marinelli C, Settevendemmie A, et al. Oxidative stress in patients affected by primary aldosteronism. J Hypertens 2014; 32: 2022-2029.
12. Anné W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 2005; 67: 655-666.
13. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, et al. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103: 72-77.
14. Chequel M, Ollitrault P, Saloux E, Parienti JJ, Fischer MO, Desgué J, et al. Preoperative plasma aldosterone levels and postoperative atrial fibrillation occurrence following cardiac surgery: A review of literature and design of the ALDO-POAF Study (Aldosterone for Prediction of Post-Operative Atrial Fibrillation). Curr Clin Pharmacol 2016; [Epub ahead of print].
15. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349.
16. Vieira MJ, Teixeira R, Gonçalves L, Gersh BJ. Left atrial mechanics: Echocardiographic assessment and clinical implications. J Am Soc Echocardiogr 2014; 27: 463-478.
17. Vianna-Pinton R, Moreno CA, Baxter CM, Lee KS, Tsang TSM, Appleton CP. Two-dimensional speckle-tracking echocardiography of the left atrium: Feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr 2009; 22: 299-305.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
19. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
20. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172.
21. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990; 100: 338-342.
22. Sezai A, Iida M, Yoshitake I, Wakui S, Osaka S, Kimura H, et al. Carperitide and atrial fibrillation after coronary bypass grafting: The Nihon University working group study of low-dose HANP infusion therapy during cardiac surgery trial for postoperative atrial fibrillation. Circ Arrhythm Electrophysiol 2015; 8: 546-553.
23. Chai W, Garrelds IM, de Vries R, Danser AHJ. Cardioprotective effects of eplerenone in the rat heart: Interaction with locally synthesized or blood-derived aldosterone? Hypertension 2006; 47: 665-670.
24. Loan Le TY, Mardini M, Howell VM, Funder JW, Ashton AW, Mihailidou AS. Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction. Hypertension 2012; 59: 1164-1169.
25. Mihailidou AS, Loan Le TY, Mardini M, Funder JW. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 2009; 54: 1306-1312.
26. Reil JC, Hohl M, Selejan S, Lipp P, Drautz F, Kazakow A, et al. Aldosterone promotes atrial fibrillation. Eur Heart J 2012; 33: 2098-2108.
27. Dumic J, Dabelic S, Flögel M. Galectin-3: An open-ended story. Biochim Biophys Acta 2006; 1760: 616-635.
28. Martínez-Martínez E, Jurado-López R, Valero-Muñoz M, Bartolomé MV, Ballesteros S, Luaces M, et al. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: Potential role in obesity. J Hypertens 2014; 32: 1104-1114.
29. Ho JE, Yin X, Levy D, Vasan RS, Magnani JW, Ellinor PT, et al. Galectin 3 and incident atrial fibrillation in the community. Am Heart J 2014; 167: 729-734.
30. Wu XY, Li SN, Wen SN, Nie JG, Deng WN, Bai R, et al. Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease. Europace 2015; 17: 1541-1547.
31. Azibani F, Benard L, Schlossarek S, Merval R, Tournoux F, Fazal L, et al. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart. Hypertension 2012; 59: 1179-1187.
32. Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: The concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil 2008; 15: 735-741.
33. Her AY, Kim JY, Kim YH, Choi EY, Min PK, Yoon YW, et al. Left atrial strain assessed by speckle tracking imaging is related to new-onset atrial fibrillation after coronary artery bypass grafting. Can J Cardiol 2013; 29: 377-383.
34. Todaro MC, Choudhuri I, Belohlavek M, Jahangir A, Carerj S, Oreto L, et al. New echocardiographic techniques for evaluation of left atrial mechanics. Eur Heart J Cardiovasc Imaging 2012; 13: 973-984.